Enliven Therapeutics, Inc. ($ELVN) Initiates Underwritten Common Stock Sale

2
Enliven Therapeutics, Inc. (Nasdaq: ELVN) has initiated an underwritten public offering of $200 million worth of its common stock shares.

The company is offering all of the shares of common stock and pre-funded warrants.

This proposed offering is subject to market and other conditions, with no guarantee of if or when it will be completed.

The actual size or terms of the offering may also vary.